Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 61

1.

Silica nanoparticles as the adjuvant for the immunisation of mice using hepatitis B core virus-like particles.

Skrastina D, Petrovskis I, Lieknina I, Bogans J, Renhofa R, Ose V, Dishlers A, Dekhtyar Y, Pumpens P.

PLoS One. 2014 Dec 1;9(12):e114006. doi: 10.1371/journal.pone.0114006. eCollection 2014.

PMID:
25436773
[PubMed - in process]
Free PMC Article
2.

Pre-clinical immunogenicity of human papillomavirus alpha-7 and alpha-9 major capsid proteins.

Bissett SL, Mattiuzzo G, Draper E, Godi A, Wilkinson DE, Minor P, Page M, Beddows S.

Vaccine. 2014 Nov 12;32(48):6548-55. doi: 10.1016/j.vaccine.2014.07.116. Epub 2014 Sep 6.

PMID:
25203446
[PubMed - in process]
Free PMC Article
3.

Unleashing the potential of NOD- and Toll-like agonists as vaccine adjuvants.

Maisonneuve C, Bertholet S, Philpott DJ, De Gregorio E.

Proc Natl Acad Sci U S A. 2014 Aug 26;111(34):12294-9. doi: 10.1073/pnas.1400478111. Epub 2014 Aug 18. Review.

PMID:
25136133
[PubMed - indexed for MEDLINE]
Free PMC Article
4.

Impact of smoking on the quantity and quality of antibodies induced by human papillomavirus type 16 and 18 AS04-adjuvanted virus-like-particle vaccine - a pilot study.

Namujju PB, Pajunen E, Simen-Kapeu A, Hedman L, Merikukka M, Surcel HM, Kirnbauer R, Apter D, Paavonen J, Hedman K, Lehtinen M.

BMC Res Notes. 2014 Jul 11;7:445. doi: 10.1186/1756-0500-7-445.

PMID:
25011477
[PubMed - indexed for MEDLINE]
Free PMC Article
5.

HPV vaccine stimulates cytotoxic activity of killer dendritic cells and natural killer cells against HPV-positive tumour cells.

Van den Bergh JM, Guerti K, Willemen Y, Lion E, Cools N, Goossens H, Vorsters A, Van Tendeloo VF, Anguille S, Van Damme P, Smits EL.

J Cell Mol Med. 2014 Jul;18(7):1372-80. doi: 10.1111/jcmm.12284. Epub 2014 Jun 30.

PMID:
24979331
[PubMed - in process]
Free PMC Article
6.

Vaccines for the 21st century.

Delany I, Rappuoli R, De Gregorio E.

EMBO Mol Med. 2014 May 6;6(6):708-20. doi: 10.1002/emmm.201403876. Review.

PMID:
24803000
[PubMed - indexed for MEDLINE]
Free PMC Article
7.

Designing vaccines for the twenty-first century society.

Finco O, Rappuoli R.

Front Immunol. 2014 Jan 23;5:12. doi: 10.3389/fimmu.2014.00012. eCollection 2014. Review.

PMID:
24478777
[PubMed]
Free PMC Article
8.

Cross-neutralizing antibodies elicited by the Cervarix® human papillomavirus vaccine display a range of Alpha-9 inter-type specificities.

Bissett SL, Draper E, Myers RE, Godi A, Beddows S.

Vaccine. 2014 Feb 26;32(10):1139-46. doi: 10.1016/j.vaccine.2014.01.008. Epub 2014 Jan 15.

PMID:
24440205
[PubMed - indexed for MEDLINE]
Free PMC Article
9.

TLR7 and 9 agonists are highly effective mucosal adjuvants for norovirus virus-like particle vaccines.

Hjelm BE, Kilbourne J, Herbst-Kralovetz MM.

Hum Vaccin Immunother. 2014;10(2):410-6. doi: 10.4161/hv.27147. Epub 2013 Nov 26.

PMID:
24280723
[PubMed - indexed for MEDLINE]
Free PMC Article
10.

Mucosal adjuvants for influenza virus-like particle vaccine.

Quan FS, Ko EJ, Kwon YM, Joo KH, Compans RW, Kang SM.

Viral Immunol. 2013 Dec;26(6):385-95. doi: 10.1089/vim.2013.0013. Epub 2013 Nov 16.

PMID:
24236855
[PubMed - indexed for MEDLINE]
Free PMC Article
11.

High-throughput pseudovirion-based neutralization assay for analysis of natural and vaccine-induced antibodies against human papillomaviruses.

Sehr P, Rubio I, Seitz H, Putzker K, Ribeiro-Müller L, Pawlita M, Müller M.

PLoS One. 2013 Oct 4;8(10):e75677. doi: 10.1371/journal.pone.0075677. eCollection 2013.

PMID:
24124504
[PubMed - indexed for MEDLINE]
Free PMC Article
12.

Adjuvant formulation structure and composition are critical for the development of an effective vaccine against tuberculosis.

Orr MT, Fox CB, Baldwin SL, Sivananthan SJ, Lucas E, Lin S, Phan T, Moon JJ, Vedvick TS, Reed SG, Coler RN.

J Control Release. 2013 Nov 28;172(1):190-200. doi: 10.1016/j.jconrel.2013.07.030. Epub 2013 Aug 9.

PMID:
23933525
[PubMed - indexed for MEDLINE]
Free PMC Article
13.

Amino acid sequence diversity of the major human papillomavirus capsid protein: implications for current and next generation vaccines.

Ahmed AI, Bissett SL, Beddows S.

Infect Genet Evol. 2013 Aug;18:151-9. doi: 10.1016/j.meegid.2013.05.013. Epub 2013 May 27.

PMID:
23722024
[PubMed - indexed for MEDLINE]
Free PMC Article
14.

A randomized, observer-blinded immunogenicity trial of Cervarix(®) and Gardasil(®) Human Papillomavirus vaccines in 12-15 year old girls.

Draper E, Bissett SL, Howell-Jones R, Waight P, Soldan K, Jit M, Andrews N, Miller E, Beddows S.

PLoS One. 2013 May 1;8(5):e61825. doi: 10.1371/journal.pone.0061825. Print 2013.

PMID:
23650505
[PubMed - indexed for MEDLINE]
Free PMC Article
15.

Influenza nucleoprotein delivered with aluminium salts protects mice from an influenza A virus that expresses an altered nucleoprotein sequence.

Macleod MK, David A, Jin N, Noges L, Wang J, Kappler JW, Marrack P.

PLoS One. 2013 Apr 16;8(4):e61775. doi: 10.1371/journal.pone.0061775. Print 2013.

PMID:
23613928
[PubMed - indexed for MEDLINE]
Free PMC Article
16.

Vaccine delivery using nanoparticles.

Gregory AE, Titball R, Williamson D.

Front Cell Infect Microbiol. 2013 Mar 25;3:13. doi: 10.3389/fcimb.2013.00013. eCollection 2013. Review.

PMID:
23532930
[PubMed - indexed for MEDLINE]
Free PMC Article
17.

Mechanism of immunopotentiation and safety of aluminum adjuvants.

Hogenesch H.

Front Immunol. 2013 Jan 10;3:406. doi: 10.3389/fimmu.2012.00406. eCollection 2012.

PMID:
23335921
[PubMed]
Free PMC Article
18.

Emerging human papillomavirus vaccines.

Ma B, Maraj B, Tran NP, Knoff J, Chen A, Alvarez RD, Hung CF, Wu TC.

Expert Opin Emerg Drugs. 2012 Dec;17(4):469-92. doi: 10.1517/14728214.2012.744393. Epub 2012 Nov 19. Review.

PMID:
23163511
[PubMed - indexed for MEDLINE]
Free PMC Article
19.

High immunogenicity of nicotine vaccines obtained by intradermal delivery with safe adjuvants.

Chen X, Pravetoni M, Bhayana B, Pentel PR, Wu MX.

Vaccine. 2012 Dec 17;31(1):159-64. doi: 10.1016/j.vaccine.2012.10.069. Epub 2012 Oct 30.

PMID:
23123021
[PubMed - indexed for MEDLINE]
Free PMC Article
20.

Immune response to vaccine adjuvants during the first year of life.

Levy O, Goriely S, Kollmann TR.

Vaccine. 2013 May 17;31(21):2500-5. doi: 10.1016/j.vaccine.2012.10.016. Epub 2012 Oct 18. Review.

PMID:
23085363
[PubMed - indexed for MEDLINE]
Free PMC Article
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk